Company Description

Zymedyne aims to develop safer and more effective treatments for chronic inflammatory and neuropathic pain by targeting Cav3.2 T-type calcium channels that are known to be crucial in pain signaling. Unlike opioids, our technology aims to achieve pain relief without the detrimental adverse effects that plague current users of chronic pain medications.